Peripheral T-cell lymphomas (PTCLs) are rare, aggressive lymphomas that affect mature T cells. “Peripheral” means the cancer developed from lymphoid tissue outside the thymus. This cancer is a subtype ...
The most common early sign of lymphoma is lymph node swelling. However, swelling of the lymph nodes does not always mean a person has cancer. Lymphoma is a general name for cancers that start in the ...
Diagnosing non-Hodgkin’s lymphoma usually starts with a physical exam, then moves to blood tests and imaging to guide next steps. A lymph node biopsy is the gold standard for lymphoma diagnosis, and ...
Peripheral T-cell lymphomas (PTCLs) represent only 10%-15% of all non-Hodgkin lymphoma but encompass a diverse group of diseases with over 30 different subtypes. As a result of both disease ...
Non-Hodgkin's lymphoma is a group of cancers that start in lymphocytes -- your immune system’s infection-fighting white blood cells. Doctors divide it into types based on the kind of lymphocyte each ...
What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease, but a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...
High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Of 406 lymph nodes, the ...
While both women and men may experience classic symptoms of lymphoma, women may have different symptoms if the lymphoma has developed in a reproductive organs. Lymphoma is a type of cancer that ...
Doru Paul, MD, is a board-certified oncologist and hematologist. He is an associate professor of clinical medicine at Weill Cornell Medical College. Swollen lymph nodes without pain may be a sign of ...
Aggressive natural killer (NK)-cell leukemia/lymphoma is a systemic NK-cell neoplasm that preferentially affects Asians with a fulminant clinical course and is almost always associated with ...
Because most current anti-cancer agents were developed using empirical screens, the molecular basis for drug sensitivity and resistance remains poorly understood. Genetic factors that influence ...